XM does not provide services to residents of the United States of America.
G
G

GlobeLife

News

Globe Life says it may face EEOC lawsuit over alleged discrimination

UPDATE 3-Globe Life says it may face EEOC lawsuit over alleged discrimination Adds response from the EEOC in paragraph 7 Sept 27 (Reuters) - Globe Life GL.N may face a lawsuit from the Equal Employment Opportunity Commission (EEOC) over alleged discrimination against six of its sales agents, the insurer disclosed in a regulatory filing on Friday. The EEOC, a federal body responsible for enforcing laws prohibiting employment discrimination, had said there was "reasonable cause" to believe the age
G

Globe Life says EEOC may sue it over alleged discrimination

Globe Life says EEOC may sue it over alleged discrimination Sept 27 (Reuters) - Insurer Globe Life GL.N said on Friday the Equal Employment Opportunity Commission (EEOC) might sue it over alleged discrimination against some of its sales agents. Reporting by Niket Nishant in Bengaluru; Editing by Anil D'Silva
G

Globe Life - Notified That EEOC Conducted Investigation Of Charges Filed Against Co And Its Unit, American Income Life Insurance Co.

BRIEF-Globe Life - Notified That EEOC Conducted Investigation Of Charges Filed Against Co And Its Unit, American Income Life Insurance Co. Sept 27 (Reuters) - Globe Life Inc GL.N : GLOBE LIFE - NOTIFIED THAT EEOC CONDUCTED INVESTIGATION OF CHARGES FILED AGAINST CO AND/OR ITS UNIT, AMERICAN INCOME LIFE INSURANCE CO. GLOBE LIFE- EEOC ASSERTS THERE IS
G

U.S. Commercial Metals, M&T Bank, Simon Property

U.S. RESEARCH ROUNDUP-Commercial Metals, M&T Bank, Simon Property Sept 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Commercial Metals, M&T Bank Corp and Simon Property Group, on Tuesday. HIGHLIGHTS * Autodesk Inc ADSK.O : Citigroup raises target price to $325 from $316 * Builders Firstsource BLDR.N : Oppenheimer raises target price to $205 from $190 * Commercial Metals Co CMC.N : Jefferies initiates with buy rat
A
B
G
H
S
A
G
I
L
M
U

U.S. Booking Holdings, Doordash, Vertex Pharmaceuticals (Aug. 5)

CORRECTED-U.S. RESEARCH ROUNDUP-Booking Holdings, Doordash, Vertex Pharmaceuticals (Aug. 5) Corrects U.S. research roundup dated Aug. 5 to remove dated research actions from headline and tables, the errors appeared in previous versions also Aug 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Booking Holdings, Doordash and Vertex Pharmaceuticals, on Monday.
A
A
B
I
M
P
A
A
E
A
E
I
A
A
A
A
F
G
H
L
L

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.